CStone Pharmaceuticals (HKG:2616)
5.36
+0.02 (0.37%)
Jul 11, 2025, 4:08 PM HKT
CStone Pharmaceuticals Revenue
In the year 2024, CStone Pharmaceuticals had annual revenue of 407.21M CNY, down -12.21%. CStone Pharmaceuticals had revenue of 153.04M in the half year ending December 31, 2024, a decrease of -30.31%.
Revenue
407.21M CNY
Revenue Growth
-12.21%
P/S Ratio
16.79
Revenue / Employee
3.02M CNY
Employees
135
Market Cap
7.27B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
BeOne Medicines | 32.49B |
Hansoh Pharmaceutical Group Company | 13.05B |
Innovent Biologics | 10.03B |
JD Health International | 61.89B |
Sino Biopharmaceutical | 30.72B |
WuXi Biologics | 19.87B |
Akeso | 2.26B |
CSPC Pharmaceutical Group | 28.99B |